[Federal Register: April 25, 2001 (Volume 66, Number 80)]
[Notices]               
[Page 20821]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ap01-61]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Molecular Target Drug Discovery for Cancer.
    Date: April 18, 2001.
    Time: 12:30 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, 6116 Executive Boulevard, 
Conference Room 8052, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Joyce C. Pegues, Ph.D., Scientific Review 
Administrator, Special Review, Referral, and Resources Branch, 
Division of Extramural Activities, National Cancer Institute, 6116 
Executive Boulevard, Room 8084, Bethesda, MD 20892, 301/594-1286.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts. Any interested person may file 
written comments with the committee by forwarding the statement to 
the Contact Person listed on this notice. The statement should 
include the name, address, telephone number and when applicable, the 
business or professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 17, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-10204 Filed 4-24-01; 8:45 am]
BILLING CODE 4140-01-M